Post-Surgery Pain Management for Orthopaedic Patients

This study is looking at different ways to manage pain after major orthopaedic surgery. Researchers want to see if giving patients a pain medication prescription without opioids (like ibuprofen, paracetamol, or ketorolac) when they leave the hospital is a good option compared to the usual care, which often includes opioids. This is a pilot study, meaning it's a smaller study to help plan a larger one in the future. They want to see if it's practical to enroll patients and follow these different pain management plans. You might be able to join if you are 18 or older and are having a major orthopaedic surgery. The study aims to enroll about 100 people. The study is currently unclear on its recruitment status.

Study design
This is a randomized controlled trial, meaning participants are randomly assigned to one of two groups. It plans to include at least 100 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed from enrollment to the end of the follow-up phase at 6 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07265557

Two Post-Operative Pain Protocols at Discharge for Orthopaedic Patients

Recruiting
NAAges 18+Interventional
Massachusetts General Hospital
~100 participants
Updated 2026-06-25 on ClinicalTrials.gov
What's tested:Discharge pain medication prescription

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility of patient enrollment and treatment allocation
Measured over From enrollment to the end of the follow-up phase at 6 weeks
Orthopaedic Related Pain (Musculoskeletal Pain)
Opioid
Pain
Pilot Study
1 sites across 1 states
Massachusetts1
  • Arun Aneja, MD PhD · PRINCIPAL_INVESTIGATOR · Massachusetts General Hospital

Opens a ready-to-send draft in your own email app — review before sending.

  • Feasibility of patient enrollment and treatment allocationFrom enrollment to the end of the follow-up phase at 6 weeks

    Participant enrollment will be assessed by monitoring screening and enrollment metrics, including: * Participant enrollment * Feasibility of treatment allocation * Data collection methods (Proportion of participants with missing data) * Compliance with the protocol (Proportion of randomization errors, proportion of patients who complete each questionnaire at each of the follow-up, proportion of patients who withdraw from the trial, proportion of participants who are lost to follow-up)